Antibiotics as a Stressing Factor Triggering the Harboring of Helicobacter pylori J99 within Candida albicans

Kimberly Sánchez-Alonzo1, Libnny Belmar1, Cristian Parra-Sepúlveda1

  • 1Laboratory of Bacterial Pathogenicity, Department of Microbiology, Faculty of Biological Sciences, Universidad de Concepción, Concepción 4070386, Chile.

Insights

Amoxicillin, but not clarithromycin, significantly increased Helicobacter pylori entry into Candida albicans yeast. This suggests amoxicillin therapy may hinder H. pylori eradication by promoting bacterial internalization.

Area of Science:

  • Microbiology
  • Medical Mycology
  • Infectious Diseases

Background:

  • First-line treatments for *Helicobacter pylori* infections involve amoxicillin and clarithromycin or metronidazole with a proton pump inhibitor.
  • Treatment failures in *H. pylori* eradication are linked to antibiotic resistance and potential internalization into host cells like yeasts.
  • The mechanisms triggering *H. pylori* entry into yeast cells remain largely unknown.

Purpose of the Study:

  • To investigate whether clarithromycin or amoxicillin exposure influences the internalization of *Helicobacter pylori* into *Candida albicans*.

Main Methods:

  • Co-culturing *H. pylori* J99 with *Candida albicans* ATCC 10231 in the presence of subinhibitory concentrations of amoxicillin and clarithromycin.
  • Assessing bacterial internalization via direct observation, viability assays, and PCR amplification of the *H. pylori* 16S rRNA gene from total yeast DNA.

Main Results:

  • Amoxicillin significantly enhanced the invasion of *H. pylori* into *C. albicans* compared to control conditions.
  • Clarithromycin did not show a significant effect on the internalization rate.

Conclusions:

  • Antibiotic-induced internalization of *H. pylori* into *C. albicans* is antibiotic-dependent.
  • Therapies incorporating amoxicillin might inadvertently promote *H. pylori* entry into *Candida*, potentially compromising treatment efficacy.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
701
Antibiotic Selection00:57

Antibiotic Selection

Overview
57.0K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
825
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
847
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
751
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
415